“Psychedelics aren't playthings,” says Andrea Jungaberle. But, with the right help, even the worst ones can unlock personal revelations.
MAPS Public Benefit Corporation (“MAPS PBC”), a clinical-stage company dedicated to changing the way mental health conditions are treated, announced...
The FDA has 60 days to decide if the application will be accepted for review. The post MAPS Submits New Drug Application to FDA for MDMA...
Historic filing marks first New Drug Application submission for any psychedelic-assisted therapy. The post Breaking News: MAPS Files New Drug Application...
Cody Shandraw is a managing partner at Ambria Capital and Co-Founder of Healing REIT, both of which are working to provide better solutions to healthcare....
Tryp Therapeutics announces signing of definitive agreement with Exopharm Limited. The post Tryp Therapeutics To Be Acquired by Exopharm appeared first...
Can psychedelics assist in recovery from eating disorders? The findings are promising, but patients and doctors need to proceed with caution until there...
A new study looks at emotionally painful, shame-related processes with psychedelic use. The post New Study Looks at Shame, Guilt and the Psychedelic Experience...
The soon-to-issue patent contains composition of matter and methods of use claims for a family of novel prodrug derivatives of psilocybin. The post Enveric...
A bipartisan group of congressional lawmakers from both the House and the Senate have added funding for studies of psychedelic therapies into a major defense...